Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Crabbe

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biochemical Society Transactions|March 21, 2007
Exploring the potential of PI3K inhibitors for inflammation and cancerT Crabbe
Methods in Enzymology|January 1, 1995
Gelatinases A and BG Murphy, T Crabbe
Addiction (Abingdon, England)|October 1, 1996
The optimal size of attributor for use with the University of Manchester Drug Misuse DatabaseT Crabbe, M Donmall
Journal of Epidemiology and Community Health|July 9, 1999
Validation of the University of Manchester Drug Misuse DatabaseT Crabbe, M Donmall, T Millar
The British Journal of Sociology|July 21, 2004
Beyond the racist/hooligan couplet: race, social theory and football cultureL Back, T Crabbe, J Solomos
European Journal of Biochemistry|December 1, 1993
Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domainT Crabbe, C Ioannou, A J Docherty
FEBS Letters|February 12, 1996
An analysis of the conformational changes that accompany the activation and inhibition of gelatinase AT Crabbe, S M Kelly, N C Price
FEBS Letters|May 23, 1994
Human progelatinase A can be activated by matrilysinT Crabbe, B Smith, J O'Connell, et al.
Trends in Biotechnology|June 1, 1992
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesA J Docherty, J O'Connell, T Crabbe, et al.
Biochemistry|December 6, 1994
Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase AT Crabbe, J P O'Connell, B J Smith, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biochemical Society Transactions|March 21, 2007
Exploring the potential of PI3K inhibitors for inflammation and cancerT Crabbe
Methods in Enzymology|January 1, 1995
Gelatinases A and BG Murphy, T Crabbe
Addiction (Abingdon, England)|October 1, 1996
The optimal size of attributor for use with the University of Manchester Drug Misuse DatabaseT Crabbe, M Donmall
Journal of Epidemiology and Community Health|July 9, 1999
Validation of the University of Manchester Drug Misuse DatabaseT Crabbe, M Donmall, T Millar
The British Journal of Sociology|July 21, 2004
Beyond the racist/hooligan couplet: race, social theory and football cultureL Back, T Crabbe, J Solomos
European Journal of Biochemistry|December 1, 1993
Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domainT Crabbe, C Ioannou, A J Docherty
FEBS Letters|February 12, 1996
An analysis of the conformational changes that accompany the activation and inhibition of gelatinase AT Crabbe, S M Kelly, N C Price
FEBS Letters|May 23, 1994
Human progelatinase A can be activated by matrilysinT Crabbe, B Smith, J O'Connell, et al.
Trends in Biotechnology|June 1, 1992
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesA J Docherty, J O'Connell, T Crabbe, et al.
Biochemistry|December 6, 1994
Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase AT Crabbe, J P O'Connell, B J Smith, et al.
Pageof 3